These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 28963556)
1. IL-17A induces heterogeneous macrophages, and it does not alter the effects of lipopolysaccharides on macrophage activation in the skin of mice. Nakai K; He YY; Nishiyama F; Naruse F; Haba R; Kushida Y; Katsuki N; Moriue T; Yoneda K; Kubota Y Sci Rep; 2017 Sep; 7(1):12473. PubMed ID: 28963556 [TBL] [Abstract][Full Text] [Related]
2. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages. Morimura S; Oka T; Sugaya M; Sato S J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687 [TBL] [Abstract][Full Text] [Related]
3. [Adipose-derived stem cells promote the polarization from M1 macrophages to M2 macrophages]. Yin X; Pang C; Bai L; Zhang Y; Geng L Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):332-8. PubMed ID: 26927552 [TBL] [Abstract][Full Text] [Related]
4. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells. Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075 [TBL] [Abstract][Full Text] [Related]
5. IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation. Kawaguchi M; Oka T; Sugaya M; Suga H; Kimura T; Morimura S; Fujita H; Sato S J Dermatol Sci; 2018 Apr; 90(1):35-45. PubMed ID: 29305258 [TBL] [Abstract][Full Text] [Related]
6. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation. Ma L; Xue H; Qi R; Wang Y; Yuan L J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162 [TBL] [Abstract][Full Text] [Related]
7. STAT1 activation represses IL-22 gene expression and psoriasis pathogenesis. Bai L; Fang H; Xia S; Zhang R; Li L; Ochando J; Xu J; Ding Y Biochem Biophys Res Commun; 2018 Jun; 501(2):563-569. PubMed ID: 29750958 [TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory activity of myricetin from Diospyros lotus through suppression of NF-κB and STAT1 activation and Nrf2-mediated HO-1 induction in lipopolysaccharide-stimulated RAW264.7 macrophages. Cho BO; Yin HH; Park SH; Byun EB; Ha HY; Jang SI Biosci Biotechnol Biochem; 2016 Aug; 80(8):1520-30. PubMed ID: 27068250 [TBL] [Abstract][Full Text] [Related]
9. Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages. Soldano S; Pizzorni C; Paolino S; Trombetta AC; Montagna P; Brizzolara R; Ruaro B; Sulli A; Cutolo M PLoS One; 2016; 11(11):e0166433. PubMed ID: 27846260 [TBL] [Abstract][Full Text] [Related]
10. PSORI-CM02 formula alleviates imiquimod-induced psoriasis via affecting macrophage infiltration and polarization. Li L; Zhang HY; Zhong XQ; Lu Y; Wei J; Li L; Chen H; Lu C; Han L Life Sci; 2020 Feb; 243():117231. PubMed ID: 31887296 [TBL] [Abstract][Full Text] [Related]
11. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling. El Malki K; Karbach SH; Huppert J; Zayoud M; Reissig S; Schüler R; Nikolaev A; Karram K; Münzel T; Kuhlmann CR; Luhmann HJ; von Stebut E; Wörtge S; Kurschus FC; Waisman A J Invest Dermatol; 2013 Feb; 133(2):441-51. PubMed ID: 22951726 [TBL] [Abstract][Full Text] [Related]
12. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation. Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470 [TBL] [Abstract][Full Text] [Related]
13. Selective inhibition and augmentation of alternative macrophage activation by progesterone. Menzies FM; Henriquez FL; Alexander J; Roberts CW Immunology; 2011 Nov; 134(3):281-91. PubMed ID: 21977998 [TBL] [Abstract][Full Text] [Related]
14. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway. Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569 [TBL] [Abstract][Full Text] [Related]
15. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells. Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823 [TBL] [Abstract][Full Text] [Related]
16. Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis. Furue M Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751111 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-33 contributes to both M1 and M2 chemokine marker expression in human macrophages. Joshi AD; Oak SR; Hartigan AJ; Finn WG; Kunkel SL; Duffy KE; Das A; Hogaboam CM BMC Immunol; 2010 Oct; 11():52. PubMed ID: 20958987 [TBL] [Abstract][Full Text] [Related]
18. Activation of Langerhans cells promotes the inflammation in imiquimod-induced psoriasis-like dermatitis. Xiao C; Zhu Z; Sun S; Gao J; Fu M; Liu Y; Wang G; Yao X; Li W J Dermatol Sci; 2017 Mar; 85(3):170-177. PubMed ID: 27964879 [TBL] [Abstract][Full Text] [Related]
19. The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Rα) signaling. Ferrante CJ; Pinhal-Enfield G; Elson G; Cronstein BN; Hasko G; Outram S; Leibovich SJ Inflammation; 2013 Aug; 36(4):921-31. PubMed ID: 23504259 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of IL-17-committed T cells in a murine psoriasis model by a vitamin D analogue. Kusuba N; Kitoh A; Dainichi T; Honda T; Otsuka A; Egawa G; Nakajima S; Miyachi Y; Kabashima K J Allergy Clin Immunol; 2018 Mar; 141(3):972-981.e10. PubMed ID: 28870465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]